LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Post-COVID-19 Cerebral Pheohyphomycosis due to Rhinocladiella mackenziei: A Middle Eastern Replica of Post-COVID-19 Mucormycosis?

Photo by lamoune from unsplash

Healthcare‐associated infections (HAIs) are not uncommon after COVID‐19. Kubin et al. reported that the incidence of post‐COVID‐19 HAIs was around 12%.[1] Out of these, 57% were bacterial and 19% were… Click to show full abstract

Healthcare‐associated infections (HAIs) are not uncommon after COVID‐19. Kubin et al. reported that the incidence of post‐COVID‐19 HAIs was around 12%.[1] Out of these, 57% were bacterial and 19% were fugal.[2] Although candidemia was the most common fungal infection, the Indian population witnessed the storm of “mucormycosis.”[2] The risk factors and the pathophysiology of post‐COVID‐19 mucormycosis are well described in medical literature.[2] Recently, we came across a case of “cerebral pheohyphomycosis (CH)” after COVID‐19.

Keywords: post; post covid; cerebral pheohyphomycosis; covid mucormycosis

Journal Title: Journal of Global Infectious Diseases
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.